Patent Trial And Appeal Board Hands Sarepta Another Big Win By: Benzinga via Benzinga September 21, 2016 at 11:50 AM EDT Sarepta Therapeutics Inc (NASDAQ: SRPT) announced Tuesday that the Patent Trial and Appeal Board issued two favorable decisions for ... Read More >> Related Stocks: Biomarin Pharmaceuticals Sarepta Therapeutics